Literature DB >> 10689154

Enhancement of immunocompetence in tuberculosis by DNA vaccination.

D B Lowrie1, C L Silva.   

Abstract

Our studies in mice show that DNA vaccines, initially designed to prevent infection, can have a dramatic therapeutic action too. In heavily infected mice, simply by giving DNA vaccination, the immune response can be caused to switch from one that is relatively inefficient and gives bacterial stasis to one that kills the bacteria, and persistent bacteria can be eliminated. Adoptive transfer of protection with T cell clones and in vitro tests of clone function indicate that the effects are probably mainly mediated by antigen specific CD8+/CD4-/CD44hi T cells that both produce gamma-interferon and kill the bacteria during granule-dependent lysis of infected macrophages. We can speculate that application of such immunotherapy in conjunction with conventional chemotherapeutic antibacterial drugs might result in faster or more certain cure of the disease in man. Furthermore, similar vaccines used prophylactically and therapeutically might be able to both prevent establishment of this persistent state and eliminate it if it is already established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689154     DOI: 10.1016/s0264-410x(99)00512-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins.

Authors:  C Peres-Buzalaf; L de Paula; F G Frantz; E M Soares; A I Medeiros; M Peters-Golden; C L Silva; L H Faccioli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-31       Impact factor: 4.006

2.  A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.

Authors:  Robert H Copenhaver; Eliud Sepulveda; Lisa Y Armitige; Jeffrey K Actor; Audrey Wanger; Steven J Norris; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model.

Authors:  Jinbiao Lu; Xiaonan Guo; Chunhua Wang; Weixin Du; Xiaobing Shen; Cheng Su; Yongge Wu; Miao Xu
Journal:  Vaccines (Basel)       Date:  2022-05-23

4.  Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis.

Authors:  Camila M Peres; Lúcia de Paula; Alexandra I Medeiros; Carlos A Sorgi; Edson G Soares; Daniela Carlos; Marc Peters-Golden; Célio L Silva; Lúcia H Faccioli
Journal:  Microbes Infect       Date:  2007-01-21       Impact factor: 2.700

Review 5.  The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy.

Authors:  Carlos Rodrigo Zárate-Bladés; Celio Lopes Silva; Geraldo A Passos
Journal:  Clin Dev Immunol       Date:  2010-12-20

6.  Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.

Authors:  Priyanka Chauhan; Ruchi Jain; Bappaditya Dey; Anil K Tyagi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation.

Authors:  Ana Paula F Trombone; Célio L Silva; Karla M Lima; Constance Oliver; Maria Célia Jamur; Alan R Prescott; Arlete A M Coelho-Castelo
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

Review 8.  Immunotherapy for tuberculosis: future prospects.

Authors:  Getahun Abate; Daniel F Hoft
Journal:  Immunotargets Ther       Date:  2016-04-20

Review 9.  Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65).

Authors:  Celio Lopes Silva; Thiago Malardo; Aline Seiko Carvalho Tahyra
Journal:  Front Med Technol       Date:  2020-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.